160 related articles for article (PubMed ID: 33487792)
1. In Silico Design and Evaluation of PRAME+FliCΔD2D3 as a New Breast Cancer Vaccine Candidate.
Taheri-Anganeh M; Savardashtaki A; Vafadar A; Movahedpour A; Shabaninejad Z; Maleksabet A; Amiri A; Ghasemi Y; Irajie C
Iran J Med Sci; 2021 Jan; 46(1):52-60. PubMed ID: 33487792
[TBL] [Abstract][Full Text] [Related]
2. In silico Evaluation of PLAC1-fliC As a Chimeric Vaccine against Breast Cancer.
Taheri-Anganeh M; Amiri A; Movahedpour A; Khatami SH; Ghasemi Y; Savardashtaki A; Mostafavi-Pour Z
Iran Biomed J; 2020 May; 24(3):173-82. PubMed ID: 31952435
[TBL] [Abstract][Full Text] [Related]
3. Immunopeptidome screening to design An immunogenic construct against PRAME positive breast cancer; An in silico study.
Afzali F; Minuchehr Z; Jahangiri S; Ranjbar MM
Comput Biol Chem; 2020 Apr; 85():107231. PubMed ID: 32065960
[TBL] [Abstract][Full Text] [Related]
4. In silico design of discontinuous peptides representative of B and T-cell epitopes from HER2-ECD as potential novel cancer peptide vaccines.
Manijeh M; Mehrnaz K; Violaine M; Hassan M; Abbas J; Mohammad R
Asian Pac J Cancer Prev; 2013; 14(10):5973-81. PubMed ID: 24289611
[TBL] [Abstract][Full Text] [Related]
5. A novel multi-epitope peptide vaccine against cancer: an in silico approach.
Nezafat N; Ghasemi Y; Javadi G; Khoshnoud MJ; Omidinia E
J Theor Biol; 2014 May; 349():121-34. PubMed ID: 24512916
[TBL] [Abstract][Full Text] [Related]
6. In Silico Approach in Designing a Novel Multi-Epitope Vaccine Candidate against Non-Small Cell Lung Cancer with Overexpressed G Protein-Coupled Receptor 56.
Herrera LRM
Asian Pac J Cancer Prev; 2020 Aug; 21(8):2297-2306. PubMed ID: 32856858
[TBL] [Abstract][Full Text] [Related]
7. The optimized fusion protein HA1-2-FliCΔD2D3 promotes mixed Th1/Th2 immune responses to influenza H7N9 with low induction of systemic proinflammatory cytokines in mice.
Song L; Xiong D; Kang X; Jiao Y; Zhou X; Wu K; Zhou Y; Jiao X; Pan Z
Antiviral Res; 2019 Jan; 161():10-19. PubMed ID: 30389471
[TBL] [Abstract][Full Text] [Related]
8. Immunoinformatics analysis of Brucella melitensis to approach a suitable vaccine against brucellosis.
Hashemzadeh P; Nezhad SA; Khoshkhabar H
J Genet Eng Biotechnol; 2023 Nov; 21(1):152. PubMed ID: 38019359
[TBL] [Abstract][Full Text] [Related]
9. Induction of Humoral and Cellular Immune Responses in Mice by Multiepitope Vaccines Composing of Both T and B Lymphocyte Epitopes of MAGE-A3 which are Recombined into HBcAg.
Chen Q; Li W; Wang P; Shao H; Ding Y; Wang W; Cen D; Cai Y; Xue X; Zhang L; Zhu G
Protein Pept Lett; 2017; 24(10):947-954. PubMed ID: 28641561
[TBL] [Abstract][Full Text] [Related]
10. Harnessing Bioinformatics for Designing a Novel Multiepitope Peptide Vaccine Against Breast Cancer.
Mahmoodi S; Nezafat N; Barzegar A; Negahdaripour M; Nikanfar AR; Zarghami N; Ghasemi Y
Curr Pharm Biotechnol; 2016; 17(12):1100-1114. PubMed ID: 27633889
[TBL] [Abstract][Full Text] [Related]
11. High-avidity cytotoxic T lymphocytes specific for a new PRAME-derived peptide can target leukemic and leukemic-precursor cells.
Quintarelli C; Dotti G; Hasan ST; De Angelis B; Hoyos V; Errichiello S; Mims M; Luciano L; Shafer J; Leen AM; Heslop HE; Rooney CM; Pane F; Brenner MK; Savoldo B
Blood; 2011 Mar; 117(12):3353-62. PubMed ID: 21278353
[TBL] [Abstract][Full Text] [Related]
12. In silico analysis of transmembrane protein 31 (TMEM31) antigen to design novel multiepitope peptide and DNA cancer vaccines against melanoma.
Safavi A; Kefayat A; Abiri A; Mahdevar E; Behnia AH; Ghahremani F
Mol Immunol; 2019 Aug; 112():93-102. PubMed ID: 31079006
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic T lymphocytes directed to the preferentially expressed antigen of melanoma (PRAME) target chronic myeloid leukemia.
Quintarelli C; Dotti G; De Angelis B; Hoyos V; Mims M; Luciano L; Heslop HE; Rooney CM; Pane F; Savoldo B
Blood; 2008 Sep; 112(5):1876-85. PubMed ID: 18591381
[TBL] [Abstract][Full Text] [Related]
14. Identification of novel HLA-restricted preferentially expressed antigen in melanoma peptides to facilitate off-the-shelf tumor-associated antigen-specific T-cell therapies.
Stanojevic M; Hont AB; Geiger A; O'Brien S; Ulrey R; Grant M; Datar A; Lee PH; Lang H; Cruz CRY; Hanley PJ; Barrett AJ; Keller MD; Bollard CM
Cytotherapy; 2021 Aug; 23(8):694-703. PubMed ID: 33832817
[TBL] [Abstract][Full Text] [Related]
15. In Silico-Guided Sequence Modification of Epitopes in Cancer Vaccine Development.
Hoo WPY; Siak PY; In LLA
Methods Mol Biol; 2020; 2131():213-228. PubMed ID: 32162256
[TBL] [Abstract][Full Text] [Related]
16. Computational prediction of vaccine potential epitopes and 3-dimensional structure of XAGE-1b for non-small cell lung cancer immunotherapy.
Tarek MM; Shafei AE; Ali MA; Mansour MM
Biomed J; 2018 Apr; 41(2):118-128. PubMed ID: 29866600
[TBL] [Abstract][Full Text] [Related]
17. Prioritization of potential vaccine candidates and designing a multiepitope-based subunit vaccine against multidrug-resistant Salmonella Typhi str. CT18: A subtractive proteomics and immunoinformatics approach.
Chand Y; Singh S
Microb Pathog; 2021 Oct; 159():105150. PubMed ID: 34425197
[TBL] [Abstract][Full Text] [Related]
18.
Kordi B; Basmenj ER; Majidiani H; Basati G; Sargazi D; Nazari N; Shams M
Biomed Res Int; 2023; 2023():3763634. PubMed ID: 37323936
[TBL] [Abstract][Full Text] [Related]
19. Design and evaluation of scFv-RTX-A as a novel immunotoxin for breast cancer treatment: an in silico approach.
Samavarchi Tehrani S; Gharibi S; Movahedpour A; Goodarzi G; Jamali Z; Khatami SH; Maniati M; Ranjbar M; Shabaninejad Z; Savardashtaki A; Taheri-Anganeh M
J Immunoassay Immunochem; 2021 Jan; 42(1):19-33. PubMed ID: 32845824
[TBL] [Abstract][Full Text] [Related]
20. In silico construction of a multiepitope Zika virus vaccine using immunoinformatics tools.
Antonelli ACB; Almeida VP; de Castro FOF; Silva JM; Pfrimer IAH; Cunha-Neto E; Maranhão AQ; Brígido MM; Resende RO; Bocca AL; Fonseca SG
Sci Rep; 2022 Jan; 12(1):53. PubMed ID: 34997041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
